The 4th Athenian Days of Interventional Oncology “Dimitrios Kelekis” (ADIO 2026) successfully concluded amid strong scientific interest. The event took place from October 9 to 11, 2026, at the Eugenides Foundation in Athens.
This significant international scientific gathering brought together distinguished physicians, professors, and researchers from Greece and abroad, providing a comprehensive platform for knowledge exchange, the presentation of modern therapeutic approaches, and discussions on the latest developments in the rapidly evolving field of Interventional Oncology.
RISALCO S.A. actively participated in the event through its educational workshops, reaffirming its ongoing commitment to technological innovation, scientific education, and support for the medical community.
A High-Level International Scientific Meeting
The conference was organized by the Hellenic Society of Nanotechnology in Health Sciences, under the scientific leadership of Professor Alexis Kelekis, with Professors Efstathios Efstathopoulos and Achilleas Chatziioannou serving as Co-Chairs.
The event is named in honor of Professor Dimitrios Kelekis, recognizing his significant contribution to the development and establishment of Interventional Radiology in Greece.
Throughout the three-day event, more than 60 distinguished scientists participated in the scientific program, presenting the latest clinical data and discussing the opportunities offered by emerging technologies for the personalized treatment of cancer.
Modern Therapeutic Techniques and Emerging Approaches
The scientific program focused on minimally invasive techniques used in the treatment of various types of cancer, with particular emphasis on effectiveness, safety, and preserving patients' quality of life.
Of particular interest were the scientific sessions addressing hepatocellular carcinoma, lung cancer, musculoskeletal tumors, and sarcomas.
Key topics included thermal tumor ablation techniques, intra-arterial therapies, radioembolization, and advanced image-guided interventions.
The role of interventional techniques in palliative care was also explored, highlighting the contribution of Interventional Oncology not only to local disease control but also to improving patients' quality of life and daily well-being.
Technology Is Shaping the Future of Interventional Oncology
Technological advancements influencing everyday clinical practice held a prominent place in the scientific program.
The use of Artificial Intelligence (AI), Augmented Reality (AR), robotic assistance, and advanced image-guided techniques were presented as essential tools for the continued development of interventional therapies.
The presentations highlighted the potential of these technologies to enhance procedural planning, improve the precision of lesion targeting, and support more accurate assessment of treatment outcomes.
Hands-On Training and RISALCO S.A.’s Participation in the Workshops
One of the key highlights of ADIO 2026 was the integration of scientific theory with practical application.
Through specialized hands-on workshops, participants had the opportunity to gain practical experience with modern techniques and advanced medical technologies.
The training sessions included ultrasound-guided techniques, the use of virtual reality simulators, and demonstrations of cryoablation technologies.
RISALCO S.A. actively participated in the event’s educational workshops, emphasizing the importance of hands-on training and familiarizing healthcare professionals with the latest technological advancements.
The company’s presence provided a valuable opportunity for communication and knowledge exchange with the scientific community, strengthening the connection between technological innovation and everyday clinical practice.
Through its participation in such educational initiatives, RISALCO S.A. highlights the importance of continuous scientific training and collaboration in advancing the fields of Interventional Radiology and Interventional Oncology.
Quality, Safety, and Multidisciplinary Collaboration
International quality and safety standards in Interventional Oncology constituted a significant part of the conference program.
The presentation of the IASIOS accreditation program and its potential implementation in Greece highlighted the importance of standardized procedures, appropriate patient selection, and systematic monitoring of treatment outcomes.
At the same time, the conference emphasized the need for close collaboration among interventional radiologists, oncologists, surgeons, and radiation oncologists, with the shared goal of selecting the most appropriate treatment strategy for each patient.
Looking Ahead to the Future of Interventional Oncology
The successful conclusion of the 4th Athenian Days of Interventional Oncology 2026 reaffirmed the importance of international scientific collaboration and the continuous advancement of therapeutic practices.
Progress in minimally invasive techniques, combined with emerging technologies and personalized treatment approaches, opens up significant opportunities for modern cancer care.
Through its presence and participation in the ADIO 2026 workshops, RISALCO S.A. reaffirmed its ongoing commitment to promoting scientific knowledge, education, and technological innovation.
With a strong focus on quality and supporting healthcare professionals, the company continues to participate in major scientific events, contributing to the dialogue and exchange of expertise that are shaping the future of Interventional Oncology.